Mayo Clinic

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer (2016) Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, et al. Journal article Genetic predisposition to ductal carcinoma in situ of the breast (2016) Petridis C, Brook MN, Shah V, Kohut K, Gorman P, Caneppele M, Levi D, et al. Journal article Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, et al. Journal article Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study (2016) Dixon SC, Nagle CM, Thrift AP, Pharoah PDP, Pearce CL, Zheng W, Painter JN, et al. Journal article Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium (2016) Muranen TA, Blomqvist C, Doerk T, Jakubowska A, Heikkila P, Fagerholm R, Greco D, et al. Journal article Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer (2016) French JD, Johnatty SE, Lu Y, Beesley J, Gao B, Kalimutho M, Henderson MJ, et al. Journal article Genomic analyses identify molecular subtypes of pancreatic cancer (2016) Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, et al. Journal article Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts (2016) Calabrese E, Maaser C, Zorzi F, Kannengiesser K, Hanauer SB, Bruining DH, Iacucci M, et al. Journal article, Review article Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer (2016) Painter JN, O'Mara TA, Marquart L, Webb PM, Attia J, Medland SE, Cheng T, et al. Journal article Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma (2016) Crump M, Leppa S, Fayad L, Lee JJ, Di Rocco A, Ogura M, Hagberg H, et al. Journal article